All Stories

  1. Exosome-like Nanovectors for Drug Delivery in Cancer
  2. Inflammation and Cancer: In Medio Stat Nano
  3. Nanoantibiotics: a new paradigm for the treatment of surgical infection
  4. Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner
  5. Bioinspired approaches for cancer nanotheranostics
  6. Effects of the protein corona on liposome–liposome and liposome–cell interactions
  7. A New Class of Phantom Materials for Poroelastography Imaging Techniques
  8. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA
  9. Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal-specific tubulin
  10. IL-4 Release from a Biomimetic Scaffold for the Temporally Controlled Modulation of Macrophage Response
  11. Cell source determines the immunological impact of biomimetic nanoparticles
  12. Case Study: Application of LeukoLike Technology to Camouflage Nanoparticles from the Immune Recognition
  13. Biomimetic Concealing of PLGA Microspheres in a 3D Scaffold to Prevent Macrophage Uptake
  14. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
  15. Microfluidic interactions between red blood cells and drug carriers by image analysis techniques
  16. Biomimetic collagenous scaffold to tune inflammation by targeting macrophages
  17. Composite microsphere-functionalized scaffold for the controlled release of small molecules in tissue engineering
  18. Antibody-mediated inhibition of Nogo-A signaling promotes neurite growth in PC-12 cells
  19. Platelet rich plasma enhances tissue incorporation of biologic mesh
  20. Multistage vector delivery of sulindac and silymarin for prevention of colon cancer
  21. Ultrasound elastography assessment of bone/soft tissue interface
  22. Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs
  23. Decreased hernia recurrence using autologous platelet-rich plasma (PRP) with Strattice™ mesh in a rodent ventral hernia model
  24. Red blood cells affect the margination of microparticles in synthetic microcapillaries and intravital microcirculation as a function of their size and shape
  25. Proteomic Profiling of a Biomimetic Drug Delivery Platform
  26. Enhanced osteogenic potential of mesenchymal stem cells from cortical bone: a comparative analysis
  27. Physicochemical properties affect pharmacokinetics of nanoporous materials
  28. Nitric oxide releasing silica nanoparticles synergize with gemcitibine to enhance cytotoxicity in pancreatic adenocarcinoma
  29. Platelet-Rich Plasma Enhances Mechanical Properties of Non-Crosslinked Acellular Dermal Matricies in Rat Model of Ventral Hernia Repair
  30. Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression
  31. Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation
  32. Continuous wound infusion of local anesthetic and steroid after major abdominal surgery: study protocol for a randomized controlled trial
  33. PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins
  34. Abstract 4536: Biomimetic carriers modulate tumor vascular barrier function
  35. Correction to Biodegradable Nanoneedles for Localized Delivery of Nanoparticles in Vivo: Exploring the Biointerface
  36. Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers
  37. Osteoprogenitor Cells from Bone Marrow and Cortical Bone: Understanding How the Environment Affects Their Fate
  38. Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
  39. Infusion of iodine-based contrast agents into poly(p-dioxanone) as a radiopaque resorbable IVC filter
  40. Mission: Nano
  41. The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation
  42. Potential Avoidance of Adverse Analgesic Effects Using a Biologically “Smart” Hydrogel Capable of Controlled Bupivacaine Release
  43. Tissue Engineering: Multiscale Patterning of a Biomimetic Scaffold Integrated with Composite MicrospheresMultiscale Patterning of a Biomimetic Scaffold Integrated with Composite MicrospheresMultiscale Patterning of a Biomimetic Scaffold Integrated with Co
  44. Abstract 4586: The Leukosome: A biomimetic liposome for the targeting of inflamed tumor vasculature
  45. Polyester Mesh Functionalization with Nitric Oxide Releasing Silica Nanoparticles Prevents MRSA Colonization and Biofilm Formation In Vitro and In Vivo
  46. Biomarker Signature Discovery from Mass Spectrometry Data
  47. Multiscale Patterning of a Biomimetic Scaffold Integrated with Composite Microspheres
  48. Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies
  49. MicroRNA and Drug Delivery
  50. Degradation and biocompatibility of multistage nanovectors in physiological systems
  51. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics
  52. A nanostructured lidocaine delivery system decreases postsurgical pain in Lewis rats
  53. Not all stem cells are created equal: a comparative analysis of osteogenic potential in compact bone and adipose-derived mesenchymal stem cells
  54. Platelet rich plasma enhances tissue deposition through increased early neovascularization on porcine acellular dermal matrices
  55. Mesoporous Silicon: Short and Long Term, In Vitro and In Vivo Correlations of Cellular and Tissue Responses to Mesoporous Silicon Nanovectors (Small 9-10/2013)
  56. Biocomposites: Silicon Micro- and Nanofabrication for Medicine (Adv. Healthcare Mater. 5/2013)
  57. Silicon Micro- and Nanofabrication for Medicine
  58. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
  59. Short and Long Term, In Vitro and In Vivo Correlations of Cellular and Tissue Responses to Mesoporous Silicon Nanovectors
  60. Evaluation of Cell Function Upon Nanovector Internalization
  61. Nanotechnologies and Regenerative Medical Approaches for Space and Terrestrial Medicine
  62. Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications
  63. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation
  64. Osteoporosis in Microgravity Environments
  65. Introduction to the World of Nanotechnology
  66. Tissue Engineering: Mesoporous Silicon-PLGA Composite Microspheres for the Double Controlled Release of Biomolecules for Orthopedic Tissue Engineering (Adv. Funct. Mater. 2/2012)
  67. Nanotechnology in Medicine: From Inception to Market Domination
  68. APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation
  69. A multifunctional nanostructured platform for localized sustained release of analgesics and antibiotics
  70. Nanomedicine: Ushering in a new era of pain management
  71. Mesoporous Silicon-PLGA Composite Microspheres for the Double Controlled Release of Biomolecules for Orthopedic Tissue Engineering
  72. Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and Therapeutics
  73. Multi-Composite Bioactive Osteogenic Sponges Featuring Mesenchymal Stem Cells, Platelet-Rich Plasma, Nanoporous Silicon Enclosures, and Peptide Amphiphiles for Rapid Bone Regeneration
  74. Agarose Surface Coating Influences Intracellular Accumulation and Enhances Payload Stability of a Nano-delivery System
  75. Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip
  76. Mass Transport via Cellular Barriers and Endocytosis
  77. Nanodevices in diagnostics
  78. Mesoporous silicon particles as intravascular drug delivery vectors: fabrication, in-vitro, and in-vivo assessments
  79. Porous Silicon Particles for Imaging and Therapy of Cancer
  80. Shaping the micromechanical behavior of multi-phase composites for bone tissue engineering
  81. Characterization of controlled bone defects using 2D and 3D ultrasound imaging techniques
  82. Enabling individualized therapy through nanotechnology
  83. Abstract LB-214: Identification of patients with adenomas or early- and late-stage colon carcinomas using nanoporous silica chips for protein profiling
  84. Tailored Porous Silicon Microparticles: Fabrication and Properties
  85. Tailoring of the Nanotexture of Mesoporous Silica Films and Their Functionalized Derivatives for Selectively Harvesting Low Molecular Weight Protein
  86. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation
  87. Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome
  88. Conference Scene: Nanotechnology and medicine: the next big thing is really small
  89. Mitotic trafficking of silicon microparticles
  90. Nanotechnology for breast cancer therapy
  91. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications
  92. In Vivo Imaging Shows Abnormal Function of Vascular Endothelial Growth Factor-Induced Vasculature
  93. Fusion of the Human Immunodeficiency Virus Type 1 Tat Protein Transduction Domain to Thymidine Kinase Increases Bystander Effect and Induces Enhanced Tumor Killing In Vivo
  94. Fusion of the Human Immunodeficiency Virus Type 1 Tat Protein Transduction Domain to Thymidine Kinase Increases Bystander Effect and Induces Enhanced Tumor Killing In Vivo
  95. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules
  96. Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat